Amphastar Pharmaceuticals, Inc. AMPH

26.13 (0.14) (0.53%) as of 25 Sep
Market cap
$1.1B
P/E
15.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Cash and Short Term Investments
74.27 72.38 93.32 89.52 109.68 139.11 178.20 259.24 224.08 285.25
Receivables
26.80 42.03 52.21 45.69 66.39 78.93 88.98 115.47 138.04 160.73
Inventory
79.75 63.61 69.32 110.50 96.83 92.81 103.58 105.83 153.74 176.89
Total current assets
184.10 187.78 220.34 255.24 279.68 318.12 378.32 489.60 534.07 636.02
Property, Plant, Equpment (Net)
152.94 180.55 210.42 233.86 260.06 244.24 238.27 282.75 297.35 310.57
Long-Term Investments
— — — — — 3.99 2.41 15.21 11.00 —
Goodwill and Intangible Assets (Total)
50.31 45.14 42.27 41.15 40.62 38.87 37.30 613.30 590.66 565.97
Long Term Assets (Tax, Deferred)
31.00 28.95 30.62 25.87 24.98 22.40 38.53 53.25 71.12 42.46
Long-term assets (Other)
9.39 8.66 9.92 11.16 5.25 16.67 20.86 25.91 25.99 31.14
Total non-current assets
243.64 263.29 293.22 331.73 351.55 353.41 363.67 1,023.31 1,043.40 993.28
Total Assets
427.74 451.07 513.56 586.97 631.24 671.53 741.99 1,512.91 1,577.47 1,629.30
Accounts Payable
47.55 57.56 87.42 77.05 95.50 89.55 84.24 93.37 157.06 148.35
Accrued Expenses
— — — — — — — 126.09 157.06 —
Current Part of Debt
5.37 6.31 18.23 7.74 12.26 2.20 3.05 0.44 0.23 1.64
Current Part of Taxes to Pay
7.71 3.33 1.19 2.04 1.08 9.08 4.57 1.61 9.66 0.24
Total current liabilities
60.62 67.19 106.83 90.01 112.20 103.81 94.86 225.41 173.76 158.16
Long Term Debt (Total)
32.36 40.84 31.98 39.39 34.19 74.78 72.84 589.58 601.63 608.75
Long Term Tax Liability (Deferred)
1.46 1.36 1.03 0.87 0.74 0.53 0.14 — — —
Non-current Liabilities (Other)
4.06 7.94 9.36 12.86 17.92 22.18 21.79 28.78 27.90 35.91
Total non-current liabilities
37.87 50.14 42.37 69.43 70.31 122.20 118.47 648.08 671.41 682.34
Total liabilities
98.48 117.34 149.20 159.44 182.51 226.01 213.33 873.49 845.17 840.49
Additional Paid In Capital
283.12 313.89 344.43 367.31 410.06 422.42 455.08 486.06 505.40 535.38
Common Stock (Net)
0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Retained Earnings
70.86 72.64 67.49 116.37 117.77 180.34 271.72 409.27 568.79 666.88
Treasury Stock
20.03 50.70 75.48 97.63 121.81 150.48 189.52 247.43 332.71 408.15
Common Equity (Total)
329.26 333.74 364.36 427.53 448.72 445.52 528.66 639.42 732.30 788.80
Shareholders Equity (Total)
329.26 333.74 364.36 427.53 448.72 445.52 528.66 639.42 732.30 788.81
Shareholders Equity and Liabilities (Total)
427.74 451.07 513.56 586.97 631.24 671.53 741.99 1,512.91 1,577.47 1,629.30
Shares (Common)
46.25 46.62 46.63 46.58 47.50 47.71 48.11 48.07 47.62 45.65
Shareholders Equity (Tangible)
278.95 288.60 322.09 386.38 408.11 406.65 491.36 26.13 141.64 222.84
Net Debt
(36.55) (25.23) (43.11) (42.38) (63.23) (62.13) (102.31) 330.77 377.78 325.14
Total Debt
37.72 47.16 50.21 47.14 46.45 76.98 75.89 590.02 601.86 610.39

Fold the line items

In millions of $ except per-share values · columns are period end dates